Published in Obesity and Diabetes Week, March 15th, 2010
"To this aim, the effect of RTZ, the PPAR gamma antagonist GW9662 and lentiviral vectors expressing interfering RNA were evaluated on human pre-adipocyte models. Two models were investigated: the human pre-adipose cell line Chub-S7 and primary pre-adipocytes derived...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.